Esophageal cancer is now the leading cause of death in Kenya, exceeding cancers of the cervix of the uterus, breast, stomach and prostate, according to reports. recent data from the World Health Organization.
This has been attributed to a late diagnosis, experts claiming that most cases are normally diagnosed at an advanced stage. Food cancer could also be linked to volcanic soils, alcohol, tobacco, chewing or smoking.
According to the data, there will be 33,978 cancer deaths in Kenya by the end of this year.
The data released Tuesday by Dr. Anne Ng'ang'a, head of the National Program against Cancer, revealed that in 2018, 4,351 deaths were due to cancer of the esophagus, or 13.5%.
Next come cervical cancer (3,286 (10%)), breast cancer (3,553 (7.7%), stomach (2,068), abdomen (1,663), colorectum (1,463) and liver cancer (1,331) in 2018.
Patients with cancer of the esophagus and stomach have difficulty swallowing, stomach pain, heartburn, bloating and rapid weight loss.
Last year, breast cancer was leading, followed by cancer of the cervix, prostate and esophagus.
However, in Africa, cervical cancer is the leading cause of death, with 81,687 deaths reported in 2018, followed by breast cancer (74,072).
Liver cancer came in third with 63,562, with prostate cancer fourth with about 43,298 deaths. No cancer linked to oesophageal cancer has been recorded in Africa.
Globocan 2018 data from the International Agency for Research on Cancer indicate that the disease will affect 18,772 women, compared to 14,215 men per year.
The research also estimated that there would be 47,887 new cases of cancer in all types of cancer, in both sexes and at all ages by the end of 2018.
Women are also leading new cases of cancer, with 28,688 cases of cancer and breast cancer leading at 5,985, followed by cervical 5,250 new cases, against 19,199 men, or 56% of total cases. new cases.
In men, prostate cancer came first, recording 2,864 new cases, followed by esophageal cancer at 2,384; colorectum came in third with 1,134 cases.
In children aged 0-19, leukemia is 16%, followed by non-Hodgkin's lymphoma 15%, kidney 6.4% and others at 44%.
Doctors associate high mortality rates with late diagnosis, shame with seeking treatment, low income and the fear of discovering that they have the disease.